This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...